CAS NO: | 1334546-77-8 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | Icenticaftor (QBW251) is an orally activeCFTRchannel potentiator, withEC50s of 79 nM and 497 nM forF508delandG551DCFTR, respectively. Icenticaftor can be used for chronic obstructive pulmonary disease (COPD) and cystic fibrosis research[1]. | ||||||||||||||||
IC50& Target | EC50: 79 nM (F508del CFTR) and 497 nM (G551D CFTR)[1] | ||||||||||||||||
体外研究 (In Vitro) | Icenticaftor (QBW251), an orally bioavailable small molecule CFTR potentiator, can restore CFTR function in specific CFTR genotypes as well as wild-type CFTR[2]. | ||||||||||||||||
体内研究 (In Vivo) | In Sprague-Dawley rats, the pharmacokinetic profile of Icenticaftor is established. After oral administration at a dose of 3 mg/kg, the oral bioavailability is 90%, and AUClastis 20 635 nmol/Loh[1]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 361.24 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C12H13F6N3O3 | ||||||||||||||||
CAS 号 | 1334546-77-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 150 mg/mL(415.24 mM;ultrasonic and warming and heat to 60℃) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|